1-5 of 5
Chiara Grana, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Enrico Derenzini, MD PhD, Angela Gueli, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Simona Sammassimo, MD, Federica Gigli, MD, Niccolo' Frungillo, MD, Riccardo Bruna, MD, Alberto Agazzi, MD, Alberto De Crescenzo, MD, Rocco Pastano, MD, Laura L Travaini, MD, Chiara Grana, MD, Laszlo Daniele, MD, William Arcese, Corrado Tarella, MD
Journal: Blood
Blood (2016) 128 (22): 3003.
https://doi.org/10.1182/blood.V128.22.3003.3003
Published: 2016
Journal Articles

High Dose 90Yttrium Ibritumomab Tiuxetan with PBSC Support in Refractory-Resistant NHL Patients.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPh, Margherita Clerici, RN, Davide Radice, ST, Stefano Papi, PhD, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1890.
https://doi.org/10.1182/blood.V110.11.1890.1890
Published: 2007
Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, PhD, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 4499.
https://doi.org/10.1182/blood.V110.11.4499.4499
Published: 2007
Journal Articles

High Dose 90 Yttrium Ibritumomab Tiuxetan (Zevalin) with PBSC Support in Refractory-Resistant NHL Patients: A Phase I/II Study.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPH, Margherita Clerici, RN, Davide Radice, ST, STefano Papi, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2720.
https://doi.org/10.1182/blood.V108.11.2720.2720
Published: 2006
Journal Articles

Efficacy of 90 Y-Ibritumomab Tiuxetan (Zevalin) in Refractory or Relapsed MALT Gastric Non Hodgkin’s Lymphoma.

Anna Vanazzi, MD, Pier F. Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2771.
https://doi.org/10.1182/blood.V108.11.2771.2771
Published: 2006